Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03291756 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CorEvitas Multiple Sclerosis (MS) Registry

StatusEnrolling by Invitation
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Dec 2, 2024, no change to tracked fieldsv9-v10
  2. Study site revisedv8
  3. Re-verified, no change to tracked fieldsv7
  4. Study description revised
    • Study title revised
    v6
  5. Eligibility criteria shortened, about 9 wordsv5
  6. 3 versions Re-verified since Dec 5, 2018, no change to tracked fieldsv2-v4
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CorEvitas
24 trials monitored
See all monitored trials
Multiple Sclerosis
1,011 trials monitored
See 34 trials at risk
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for MS in a cohort of patients cared for by neurologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Trial Details
NCT Number NCT03291756
Lead Sponsor CorEvitas
Conditions
(from sponsor)		 Multiple Sclerosis
Related terms Multiple Sclerosis
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov